Команда «Р-Фарм»

Alexey Repik
Chairman of the Board "R-Pharm" JSC
R-Pharm Founder. Graduated from the State University Higher School of Economics, Diploma in Economy and Business Management. Since 1995 in Healthcare and Pharmaceutics.
Vasily Ignatiev
Since 2008 has worked at R-Pharm as Director for Business Development, then CEO. 5 years at the Russian headquarters of the international pharmaceutical company AstraZeneca in the position of Marketing Director, Sales and Marketing Director, National Sales Director. 7 years at the Russian headquarters of the international pharmaceutical company Bristol-Myers Squibb in the position of Product Manager, Franchise Manager, Marketing Director. In 1998-1999 spent 7 months on secondment at the global marketing group of BMS corporate headquarters in Princeton, NJ. MD – diploma with honors, Moscow Sechenov Medical Academy (incl. 6 months elective courses at Columbia University College of Physicians and Surgeons (Ney York, NY)). Major in clinical pharmacology. PhD – Moscow Sechenov Medical Academy & Russian Academy of Medical Sciences. MBA – Moscow MIRBIS business school & London Guildhall University.
Valery Pereletov
Senior VP
Graduated from Moscow Pedagogic State University, got degree of INSEAD business-school (France, Fontainebleau). In 1994 – 1996 Valery managed the Russian office of UPSA company. During the period from 1996 to 2009 he was working in the Russian representative office of pharmaceutical company Bristol-Myers Squibb, being the Head of OTC drugs division (after the purchase of UPSA company) and further in 1999 being appointed to the position of Vice-president, Sales & Commercial Affairs. Then, in 2007 – 2009 Valery was working as VP, Market Access & Business Development. In 2009 – 2012 he filled the position of VP on creative business and TV-production in communication holding “Media Arts Group”. Came back to R-Pharm in 2012 to become VP on commercial affairs. In 2019 was assigned on a post of senior VP.
Anastasia Batrak
Vice President for Strategic Marketing and Product Portfolio Development
Graduated from the Faculty of Biology, Lomonosov Moscow State University with a major in Biochemistry, worked as a research officer at the Institute of Bioorganic Chemistry, and later worked in different capacities in the medical department, marketing and pharmacoeconomics department in such companies as BMS, Janssen, Pfizer. Since May 2014 was in charge of Virology department in R-Pharm company. In 2017, she was appointed to the position of Vice President for Strategic Marketing and Product Portfolio development.
Ivan Semenov
VP – HR & Organizational Development, R-Pharm Germany site leader
Ivan Semenov holds a Political Science degree from the Russian State University for Humanities. Since 2002, he has been working in human resources management and consulting. He held a number of positions in such large automotive companies as Sollers and Ford Motor Company. Since January 2015, he is responsible for the strategy of human resources management and organizational development at the R-Pharm group of companies. In 2020 was assigned to the post of the site leader at R-Pharm Germany GmbH.
Anna Surova
Vice President for Procurement and Supply Chain Management
Graduated from Russian State University for the Humanities. In pharmaceutical industry since 2000. She used to work for one of the largest Russian pharmaceutical companies. In November 2011 she was appointed Head of Customer Service Section, R-Pharm. Today, she heads Procurement and Supply Chain Management.
Larisa Smirnova
VP - Oncology
Anna graduated from the Russian State University for the Humanities with a degree in Philology. In 2002, she joined the R-Pharm Group of Companies as the Head of the Regional Sales Department, in 2007 she was transferred to the position of the Head of the Customer Service Department, and in 2008 she was appointed the Director of the Customer Service Department. Thanks to Anna's work, R-Pharm has built and is constantly improving the procurement process, ensured effective delivery and shipment times, introduced and operates a modern ERP system. In 2019 was appointed as Vice-president in charge of company's oncology portfolio.
Valeria Povolotsky
VP – Global Partnering R-Pharm Overseas, Inc
She has more than 15 years experience in Drug Development and over 10 years in Global Business Development, including Licensing, M&A, and Venture investments. Having academic education in science, Master degree in Biological Chemistry and Ph.D in Clinical Pharmacology, Dr. Povolotsky was involved in development of 14 drugs, which are currently on the markets in different countries; she served as an R&D Head of two biotech companies in Israel, Lean-Ex and Modus Biological Membranes, as an investment expert at Magellan Summit Ventures, and the Director of Scientific Intelligence of Japanese company Daiichi Sankyo. Before her coming to R-Pharm as a Vice President of Global Partnering, Valeria was a Director of the Global Business Development at one of the biggest Pharmaceutical Company, Hoffmann La-Roche, responsible for Partnering in Emerging Markets. As of now, she is leading strategy and execution of the International Partnering operations, bringing R-Pharm to the Global Markets.
Yan Lavrovsky
CEO and CSO R-Pharm Overseas, Inc
Yan Lavrovsky came from Avineuro Pharmaceuticals, Inc., where as a CEO and Director of Clinical Development Yan led projects in Alzheimer’s disease and schizophrenia taking two molecules into late stages of clinical development. Previously, Yan held executive positions in ChemDiv, Inc. and Serono, Geneva, Switzerland and Boston, Massachusetts where he led several programs in CNS, oncology and autoimmune diseases through late stages of clinical development. Yan is a trained physician with a Ph.D. in Molecular Biology and completed post-doctoral training at the Rockefeller University, New York, NY. Before joining Serono in 2001 Yan was a faculty member at the University of Texas, Health Science Center. During his tenure at the University of Texas, Yan was a principal investigator on NIH-funded projects. Yan is the author of more than 50 original reviews, original research articles, patents, and various book chapters.
Andrey Burkhanov
Commercial Director
Has graduated from the 1st Setchenov Moscow Medical Institute. Has experience in Russia and abroad. Before R-Pharm he worked as Market Access Director in Schering-Plough Russia; earlier – as Commercial Director in AstraZeneca Russia and Deputy Commercial Director in Roche-Moscow.
Mikhail Samsonov
Chief Medical Officer
He manages and establishes all development activities in R-Pharm. With over 17 years of experience at BMS and Novartis in variety of senior / executive roles in medical affairs and clinical operations, Dr Samsonov has dedicated much of his career to building capabilities in fast-growing clinical research markets, continuous productivity improvement in well established R&D markets and developing 10 new molecules in several areas (antiinfective, autoimmune, CNS, CVS, oncology, virology). He was based at several BMS offices in the US, UK, Russia and Belgium. Dr. Samsonov holds a medical degree in Internal Medicine (Moscow Medical University, Russia), specialization in Cardiology and Ph.D. in Cardiology & Immunology (National Cardiology Centre, Moscow, Russia), completed business courses in Open University and INSEAD.
Andrey Artemov
Сhief Operating Officer
Studied in Moscow State Technical University. Has over 15 years of experience in pharmaceutical business. He has been working as a Deputy CEO of a major Russian pharmaceutical company since 1996. In the period between 2001 and 2012 he was holding a position of an Executive Officer in R-Pharm. Since 2012 he is Chief Commercial Officer of R-Pharm.